285 related articles for article (PubMed ID: 15113856)
1. p73alpha is a candidate effector in the p53 independent apoptosis pathway of cisplatin damaged primary murine colonocytes.
Oniscu A; Sphyris N; Morris RG; Bader S; Harrison DJ
J Clin Pathol; 2004 May; 57(5):492-8. PubMed ID: 15113856
[TBL] [Abstract][Full Text] [Related]
2. Induction of p21 and nuclear accumulation of TAp73alpha and c-abl during apoptosis of cisplatin-treated primary pancreatic acinar cells.
Sphyris N; Morris RG; Harrison DJ
Int J Oncol; 2004 Dec; 25(6):1661-70. PubMed ID: 15547703
[TBL] [Abstract][Full Text] [Related]
3. p73alpha regulates the sensitivity of bone marrow mesenchymal stem cells to DNA damage agents.
Liang W; Lu C; Li J; Yin JQ; Zhao RC
Toxicology; 2010 Mar; 270(1):49-56. PubMed ID: 20100536
[TBL] [Abstract][Full Text] [Related]
4. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
Di Como CJ; Gaiddon C; Prives C
Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077
[TBL] [Abstract][Full Text] [Related]
5. p73alpha expression induces both accumulation and activation of wt-p53 independent of the p73alpha transcriptional activity.
Miro-Mur F; Meiller A; Haddada H; May E
Oncogene; 2003 Aug; 22(35):5451-6. PubMed ID: 12934105
[TBL] [Abstract][Full Text] [Related]
6. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.
Fillippovich I; Sorokina N; Gatei M; Haupt Y; Hobson K; Moallem E; Spring K; Mould M; McGuckin MA; Lavin MF; Khanna KK
Oncogene; 2001 Jan; 20(4):514-22. PubMed ID: 11313982
[TBL] [Abstract][Full Text] [Related]
7. ING1b decreases cell proliferation through p53-dependent and -independent mechanisms.
Tsang FC; Po LS; Leung KM; Lau A; Siu WY; Poon RY
FEBS Lett; 2003 Oct; 553(3):277-85. PubMed ID: 14572637
[TBL] [Abstract][Full Text] [Related]
8. Wild-type p53 and p73 negatively regulate expression of proliferation related genes.
Scian MJ; Carchman EH; Mohanraj L; Stagliano KE; Anderson MA; Deb D; Crane BM; Kiyono T; Windle B; Deb SP; Deb S
Oncogene; 2008 Apr; 27(18):2583-93. PubMed ID: 17982488
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
Das S; El-Deiry WS; Somasundaram K
J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
[TBL] [Abstract][Full Text] [Related]
10. p73-dependent apoptosis through death receptor: impairment by human cytomegalovirus infection.
Terrasson J; Allart S; Martin H; Lulé J; Haddada H; Caput D; Davrinche C
Cancer Res; 2005 Apr; 65(7):2787-94. PubMed ID: 15805279
[TBL] [Abstract][Full Text] [Related]
11. MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function.
Azmi AS; Aboukameel A; Banerjee S; Wang Z; Mohammad M; Wu J; Wang S; Yang D; Philip PA; Sarkar FH; Mohammad RM
Eur J Cancer; 2010 Apr; 46(6):1122-31. PubMed ID: 20156675
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells.
Million K; Horvilleur E; Goldschneider D; Agina M; Raguénez G; Tournier F; Bénard J; Douc-Rasy S
Int J Oncol; 2006 Jul; 29(1):147-54. PubMed ID: 16773194
[TBL] [Abstract][Full Text] [Related]
13. Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function.
Hanamoto T; Ozaki T; Furuya K; Hosoda M; Hayashi S; Nakanishi M; Yamamoto H; Kikuchi H; Todo S; Nakagawara A
J Biol Chem; 2005 Apr; 280(17):16665-75. PubMed ID: 15723830
[TBL] [Abstract][Full Text] [Related]
14. Effects of p73 gene overexpression on apoptosis and chemosensitivity of human lung adenocarcinoma cell line A549.
He Y; Fan SZ; Jiang YG
Ai Zheng; 2006 Aug; 25(8):925-32. PubMed ID: 16965670
[TBL] [Abstract][Full Text] [Related]
15. Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells.
Tyagi S; Bhui K; Singh R; Singh M; Raisuddin S; Shukla Y
Biochem Pharmacol; 2010 Nov; 80(9):1326-34. PubMed ID: 20655883
[TBL] [Abstract][Full Text] [Related]
16. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria.
John K; Alla V; Meier C; Pützer BM
Cell Death Differ; 2011 May; 18(5):874-86. PubMed ID: 21127500
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of p73 by nuclear IkappaB kinase-alpha mediates cisplatin-induced apoptosis.
Furuya K; Ozaki T; Hanamoto T; Hosoda M; Hayashi S; Barker PA; Takano K; Matsumoto M; Nakagawara A
J Biol Chem; 2007 Jun; 282(25):18365-18378. PubMed ID: 17452332
[TBL] [Abstract][Full Text] [Related]
18. Ruthenium (II)-derived organometallic compounds induce cytostatic and cytotoxic effects on mammalian cancer cell lines through p53-dependent and p53-independent mechanisms.
Gaiddon C; Jeannequin P; Bischoff P; Pfeffer M; Sirlin C; Loeffler JP
J Pharmacol Exp Ther; 2005 Dec; 315(3):1403-11. PubMed ID: 16169939
[TBL] [Abstract][Full Text] [Related]
19. p73 can suppress the proliferation of cells that express mutant p53.
Willis AC; Pipes T; Zhu J; Chen X
Oncogene; 2003 Aug; 22(35):5481-95. PubMed ID: 12934108
[TBL] [Abstract][Full Text] [Related]
20. Kinase activity-independent suppression of p73alpha by AMP-activated kinase alpha (AMPKalpha).
Lee YG; Lee SW; Sin HS; Kim EJ; Um SJ
Oncogene; 2009 Feb; 28(7):1040-52. PubMed ID: 19079340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
